1. What Happened? The Biomed Receives an Auditor Disclaimer

The Biomed recently received an auditor disclaimer on its financial statements. This casts significant doubt on the reliability of the company’s financial information and severely undermines investor confidence. The possibility of trading suspension exists, demanding investor caution.

2. Why Did This Happen? Deteriorating Financials and Uncertain Management

The primary reasons for the disclaimer are the company’s deteriorating financial health and uncertain management. Consistent operating and net losses, frequent changes in major shareholders, and a history of regulatory sanctions raise serious concerns about the company’s stability. Sales have declined significantly since the COVID-19 boom, and the success of new business ventures remains uncertain.

3. What Should Investors Do? Action Plan

  • Understand the Disclaimer: Determine the specific reasons for the auditor disclaimer and critically assess the company’s proposed solutions.
  • Evaluate New Business Performance: Analyze the actual performance and future prospects of The Biomed’s ventures in functional foods and digital healthcare.
  • Scrutinize Financial Improvement Plans: Carefully examine the company’s plans for improving its financial structure, assessing their feasibility and potential impact on short-term and long-term stability.
  • Assess Management Stability: Consider the history of frequent changes in major shareholders and evaluate the current management’s stability and commitment to the business.

4. Investment Decision: Proceed with Extreme Caution

The Biomed has potential opportunities, including the growing in vitro diagnostics market and its expansion into new business areas. However, the auditor disclaimer is a critical issue that must be resolved before any investment is considered. Investors should closely monitor the situation, focusing on the resolution of the disclaimer and tangible improvements in the company’s fundamentals before making any investment decisions. Hasty investments could lead to substantial losses.